Corrona Japan Rheumatoid Arthritis (RA) Registry

Not Applicable

Recruiting

• Conditions: Rheumatoid Arthritis

• Registration Number: JPRN-UMIN000021394
• Lead Sponsor: CorEvitas, LLC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-08
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2600

Inclusion Criteria

Not provided

Exclusion Criteria

NA

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective is to prospectively study the comparative effectiveness and comparative safety of approved therapies for RA in a Japanese cohort of patients treated by rheumatologists. Specifically the effectiveness and safety of newer classes and dosages of DMARDs (e.g. higher dose MTX, non-TNF biologics, and JAK inhibitors) will be compared with anti-TNF biologics.

Secondary Outcome Measures

Name	Time	Method
Secondary objectives include analyzing the epidemiology and natural history of the disease, comorbidities, and current treatment practices.